Foreign and local companies miss out on Korean OTC derivatives licences


US banks Citi and Morgan Stanley, along with Korean firms Hanwha Securities and SK Securities, have missed out in the most recent round of applications for South Korean over-the-counter (OTC) derivatives licences.

The firms made their applications in June for the country's highest level of dealing licence - along with Dongbu Securities and Seoul Securities, both based in Seoul - but withdrew in July after being audited by the regulator, the Financial Supervisory Service (FSS).

The FSS was due

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: